Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
22.29B | 21.20B | 21.01B | 20.30B | 20.73B | 20.72B | Gross Profit |
22.14B | 21.20B | 21.01B | 20.30B | 20.73B | 20.72B | EBIT |
4.75B | 2.07B | 2.54B | 2.46B | 1.82B | 2.62B | EBITDA |
1.93B | 2.72B | 3.33B | 3.21B | 2.64B | 3.32B | Net Income Common Stockholders |
832.00M | 1.25B | 1.60B | 1.61B | 877.00M | 1.35B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
57.26B | 64.52B | 108.97B | 128.42B | 160.63B | 81.07B | Total Assets |
1.15T | 1.14T | 1.19T | 1.21T | 1.24T | 1.12T | Total Debt |
51.44B | 43.35B | 66.05B | 102.52B | 105.81B | 66.97B | Net Debt |
-5.82B | -64.52B | -42.92B | -25.90B | -54.82B | -14.09B | Total Liabilities |
1.09T | 1.08T | 1.11T | 1.14T | 1.17T | 1.05T | Stockholders Equity |
55.51B | 58.65B | 73.77B | 71.32B | 72.55B | 66.80B |
Cash Flow | Free Cash Flow | ||||
0.00 | -23.71B | -32.97B | -35.05B | 79.31B | 17.73B | Operating Cash Flow |
0.00 | -21.82B | -31.98B | -34.28B | 80.49B | 18.19B | Investing Cash Flow |
0.00 | -5.94B | 6.11B | 2.49B | -513.00M | -3.03B | Financing Cash Flow |
0.00 | -17.96B | 6.35B | -462.00M | -442.00M | -447.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | $903.59B | 12.14 | 6.30% | 3.04% | 9.55% | 9.39% | |
70 Outperform | $727.43B | 11.98 | 7.30% | 3.43% | 15.35% | -1.62% | |
66 Neutral | ¥68.33B | 10.55 | 3.09% | -6.07% | 21.28% | ||
64 Neutral | $12.73B | 9.82 | 7.91% | 17015.08% | 12.18% | -5.69% | |
62 Neutral | ¥7.46B | 10.03 | 3.36% | -1.88% | -57.55% |